Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
954
archived clinical trials in
Fibromyalgia

Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Greenville, SC
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Chattanooga, TN
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Franklin, TN
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Franklin, TN
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Knoxville, TN
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Memphis, TN
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Austin, TX
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Houston, TX
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
San Antonio, TX
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Norfolk, VA
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Richmond, VA
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Bellevue, WA
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Richland, WA
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Richland, WA
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
mi
from
Caba,
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
mi
from
Caba,
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Rochester Hills, MI
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/11/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Treatment of Pain Associated With Fibromyalgia
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/11/2018
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Juvenile Primary Fibromyalgia Syndrome (JPFS) in an Adolescent Psychiatric Population
Juvenile Primary Fibromyalgia in a Female Adolescent Psychiatric Population
Status: Enrolling
Updated:  1/19/2018
University of Kentucky
mi
from
Lexington, KY
Juvenile Primary Fibromyalgia Syndrome (JPFS) in an Adolescent Psychiatric Population
Juvenile Primary Fibromyalgia in a Female Adolescent Psychiatric Population
Status: Enrolling
Updated: 1/19/2018
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Botox for Treatment of TMJ Disorder With Bruxism
Phase 1 Study of Role of Botox in Myofascial Temporomandibular Disorder
Status: Enrolling
Updated:  1/21/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Botox for Treatment of TMJ Disorder With Bruxism
Phase 1 Study of Role of Botox in Myofascial Temporomandibular Disorder
Status: Enrolling
Updated: 1/21/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Iron Deficient Patients With Fibromyalgia
Status: Enrolling
Updated:  1/22/2018
Clinical Research Solutions
mi
from
Franklin, TN
Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia
A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer (Ferric Carboxymaltose) in the Treatment of Iron Deficient Patients With Fibromyalgia
Status: Enrolling
Updated: 1/22/2018
Clinical Research Solutions
mi
from
Franklin, TN
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/25/2018
Achieve Clinical Research
mi
from
Birmingham, AL
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/25/2018
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/25/2018
Superior Research LLC
mi
from
Sacramento, CA
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/25/2018
Superior Research LLC
mi
from
Sacramento, CA
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/25/2018
Chicago Research Center, Inc
mi
from
Chicago, IL
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/25/2018
Chicago Research Center, Inc
mi
from
Chicago, IL
Click here to add this to my saved trials
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  1/25/2018
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - 202
A Double-Blinded, Randomized, Sham-Controlled, Study of the Revised NeuroPoint Device for the Treatment of Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 1/25/2018
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Birmingham, AL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Mobile, AL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Phoenix, AZ
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Anaheim, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Los Alamitos, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Los Angeles, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Newport Beach, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Rancho Mirage, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Roseville, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
San Diego, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Santa Ana, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Santa Barbara, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Santa Monica, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Santa Monica, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Spring Valley, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Thousand Oaks, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Tustin, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Walnut Creek, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Cromwell, CT
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Cromwell, CT
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Bradenton, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Brandon, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Brooksville, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Brooksville, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Clearwater, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Clearwater, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Coral Springs, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Coral Springs, FL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials